₹1052.9
10.8 (1.04%) - 11 Aug 2025 04:28 PMAurobindo Pharma Limited continues to be one of the world’s fastest growing Active Pharmaceutical Ingredients (API) manufacturing companies, driven by cost leadership, flexibility to produce multiple products in the same manufacturing facilities and capabilities in various therapeutic domains. Its API business has ensured the profitability and growth of its formulations business through seamless vertical integration. Its API business is supported by technologically advanced research and development infrastructure, which develops new products and plays a role in the delivery of products to the market. It has built a strong presence in key therapeutic segments such as Central nervous system (CNS), cardiovascular (CVS), anti-retroviral (ARV), anti-diabetics, gastroenterology and antibiotics. Also, it is building a diversified pipeline in high-margin specialty generic formulations segment.
Industry - Pharmaceuticals & Drugs
* Please refer to the Standalone data if Consolidated financial data for the company is not available.
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED
| All logos and Trademarks registered with their respective owners.
